期刊文献+

人重组催乳素蛋白的原核表达、纯化及其稳定性分析

Prokaryotic expression,purification and stability of recombinant human prolactin protein
原文传递
导出
摘要 目的表达并纯化重组人催乳素(prolactin,PRL)蛋白,并检测其抗原性及稳定性。方法以商品化的PRL c DNA为模板,PCR扩增目的基因,定向克隆至质粒p ET25中,构建重组原核表达质粒PRL-p ET25b,转化大肠埃希菌后诱导表达,产物经Ni-NTA亲和层析柱纯化,SDS-PAGE鉴定后,采用Bradford法测定蛋白浓度,PRL定量试剂盒分析抗原性,置-20、4和37℃9 d后,分析稳定性。结果重组表达质粒经双酶切及测序鉴定证明构建正确,表达的重组PRL蛋白相对分子质量约30 000,以包涵体形式存在,表达量占菌体总蛋白的15%,纯度大于90%,总蛋白浓度为0.796 mg/ml。重组PRL蛋白于-20、4和37℃放置9 d,浓度变化较小,偏差在10%以内。结论获得了高纯度的重组PRL融合蛋白,抗原性及稳定性均较好,可应用于试剂盒标准品或校准品的制备。 Objective To express and purify recombinant human prolactin (PRL) protein and determine its antigenieity and stability. Methods Target gene was amplified by PCR using commercial PRL eDNA as a template and cloned into plasmid pET25b. The constructed recombinant plasmid PRL-pET25b was transformed to E. coli and induced with IPTG, and the expressed protein was purified by Ni-NTA chromatography, identified by SDS-PAGE, determined for concentration by Bradford method, and analyzed for antigenicity by PRL quantitative detection kit, then stored at -20, 4 an 37 ℃ for 9 d respectively and evaluated for stability. Results Restriction analysis and sequencing proved that recombinant plasmid PRL-pET25b was constructed correctly. The expressed PRL protein, with a relative molecular mass of about 30 000, exist- ed in a form of inclusion body and contained about 15% of total somatic protein, of which the purity was more than 90% and the total protein content was 0. 796 mg/mL After storage at -20, 4 an 37 ℃ for 9 d, the variation of PRL concentration was less than 10%. Conclusion Highly purified recombinant PRL fusion protein was obtained, which showed good antigenicity and stability and might be used for the preparation of standard kit and calibrator.
出处 《中国生物制品学杂志》 CAS CSCD 2015年第4期352-355,共4页 Chinese Journal of Biologicals
关键词 PRL 原核细胞 基因表达 纯化 抗原性 稳定性 PRL Prokaryotie expression Gene expression Purification Antigenicity Stability
  • 相关文献

参考文献10

  • 1Freeman ME,Kanyicska B,Lerant A,et al.Prolactin:structure,function,and regulation of secretion[J].Physiol Rev,2000,80(4):1523-1631.
  • 2Seo YA,Lee S,Hennigar SR,et al.Prolactin(PRL)-stimulated ubiquitination of Zn T2 mediates a transient increase in zinc secretion followed by Zn T2 degradation in mammary epithelial cells[J].J Biol Chem,2014,289(34):23653-23661.
  • 3Hartwell HJ,Petrosky KY,Fox JG,et al.Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice[J].Proc Natl Acad Sci USA,2014,111(31):11455-11460.
  • 4Barry JA,Moran E,Parekh HS,et al.Prolactin and aggression in women with fertility problems[J].J Obstet Gynaecol,2014,34(7):605-610.
  • 5Frantsiyants E,Bandovkina V,Komarova E,et al.Content of sex steroids and prolactin in tumor tissue in breast cancer[J].J Clin Oncol,2014,32(Suppl 15):e22238.
  • 6Legostayev V,Frantsiyants E,Bandovkina V,et al.Gender distinctions in the content of prolactin and progesterone in lung cancer tumor knot[C].ASCO Meeting,2014:e22204.
  • 7Haring R,Friedrich N,Vlzke H,et al.Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality[J].Eur Heart J,2014,35(18):1215-1221.
  • 8黄颖,沈洪征,徐立根,李波,冷炜.关于重组人泌乳素制剂作为推荐的WHO参考试剂的评估[J].中国药事,2006,20(4):218-222. 被引量:3
  • 9WHO Reference Reagent Instructions for Use.Prolactin,Human,recombinant,non-glycosylated[S].NIBSC code:98/582.2008,1,14.
  • 10WHO Reference Reagent Instructions for Use.Prolactin Human,recombinant,glycosylated[S].NIBSC code:98/580.2008,1,14.

二级参考文献4

  • 1周海钧 申蕴如.生物检定统计方法[M](第2版)[M].北京:人民卫生出版社,1988.86-87.
  • 2中华人民共和国卫生部药政管理局.放射性核素标记分析药盒质量标准[Z].卫药发(1995)第88号文件.
  • 3Schulster D, Gaines Das RE, Jeffcoate SL. International standards for human prolactin: calibration by international collaborative study[J]. J Endocrinol, 1989,121 : 157.
  • 4徐立根,沈洪征,钱德明,刘群丽.尿促卵泡激素和促黄体生成激素国际标准品协作标定[J].中国药事,2003,17(4):248-249. 被引量:6

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部